Kelleher Financial Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.9K Hold
240
0.02% 348
2025
Q4
$57.8K Hold
240
0.01% 384
2025
Q3
$65.7K Buy
+240
New +$65.6K 0.02% 311

Other funds holding RMD

Kelleher Financial Advisors's RMD Position: Q1 2026 in Review

Kelleher Financial Advisors held its ResMed (RMD) position steady in Q1 2026 at 240 shares worth $61.9K. The position accounts for 0.02% of the portfolio, ranked #348.

Kelleher Financial Advisors first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $65.7K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Kelleher Financial Advisors held 240 shares of ResMed worth $61.9K as of Q1 2026.
  • Kelleher Financial Advisors left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.02% of Kelleher Financial Advisors's portfolio in Q1 2026, its #348 holding.
  • Kelleher Financial Advisors first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Kelleher Financial Advisors's ResMed position peaked at $65.7K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Kelleher Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.